EODData

MEMBERSHIP REGISTER LOG IN

FRA, 0PQ: PROQR THERAPEUTICS EO-04

12 Nov 2025
LAST:

1.815

CHANGE:
 0.00		OPEN:
1.815		HIGH:
1.815		ASK:
0.000		VOLUME:
758
CHG(%):
0.00		PREV:
1.815		LOW:
1.815		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
12 Nov 251.8151.8151.8151.815758
11 Nov 251.8151.8151.8151.815758
07 Nov 251.8601.8601.8601.860758
06 Nov 252.0142.0142.0142.014758
05 Nov 252.0162.0162.0162.016758
04 Nov 252.1962.1962.1962.196758
31 Oct 252.2762.2762.2762.276200
30 Oct 252.2062.2062.2062.206200
29 Oct 252.3762.3762.3762.376200
28 Oct 252.3562.3562.3562.356200

COMPANY PROFILE

Name:PROQR THERAPEUTICS EO-04
About:ProQR Therapeutics N.V., a biotechnology company, focuses on the discovery and development of novel therapeutic medicines. The company's products pipeline includes AX-0810 for cholestatic diseases targeting Na-taurocholate cotransporting polypeptide (NTCP); and AX-1412 for cardiovascular diseases (CVDs) targeting Beta-1,4-galactosyltransferase 1 (B4GALT1). It also develops various other early-stage research programs, including AX-1005 for undisclosed targets in CVDs; AX-2402, which focuses on Rett syndrome; AX-2911 for metabolic dysfunction-associated steatohepatitis (MASH) targeting patatin-like phospholipase domain-containing protein 3 (PNPLA3); AX-0601 for obesity and Type 2 diabetes; and AX-9115 for rare metabolic condition, as well as additional programs in Rett Syndrome, additional CNS programs, and multiple other unnamed targets and programs. In addition, the company develops Axiomer RNA base-editing platform technology. It has a license agreement with Radboud University Medical Center; Inserm Transfert SA; Ionis Pharmaceuticals, Inc.; Vico Therapeutics B.V.; University of Rochester; and Leiden University Medical Center, as well as license and research collaboration with Eli Lilly and Company for the discovery, development, and commercialization of potential new medicines for genetic disorders in the liver and nervous system. The company was incorporated in 2012 and is headquartered in Leiden, the Netherlands.
Sector:Healthcare
Industry:Biotechnology
Address:Zernikedreef 9, Leiden, Netherlands, 2333 CK
Website:https://www.proqr.com
ISIN:NL0010872495

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-6.86 
Forward P/E:-2.03 
PEG Ratio:-0.02 
Price to Sales:15.49 
Price to Book:3.80 
Profit Margin:-2.31 
Operating Margin:-3.08 
Return on Assets:-0.20 
Return on Equity:-0.79 
Revenue:17.14M 
Shares:105.34M 
Market Cap:191.2M 

TECHNICAL INDICATORS

MA5:1.904.9%
MA10:2.0915.3%
MA20:2.1920.6%
MA50:2.0010.3%
MA100:1.904.8%
MA200:1.772.8%
RSI14:22.17 
WPR14:-100.00 
MTM14:-0.66
ROC14:-0.27 
ATR:0.10 
Week High:2.0211.1%
Week Low:1.820.0%
Month High:2.5640.9%
Month Low:1.822.8%
Year High:3.64100.3%
Year Low:0.9689.5%